The National Institute of Diabetes & Digestive & Kidney Diseases

• Epidemiological studies and clinical trials in urology and chronic kidney disease

• Strategy development for designing national programs to prevent and treat chronic diseases (chronic kidney disease, non-malignant urologic conditions, lung and respiratory diseases)

• Program evaluation of treatment interventions (design, analysis and interpretation of randomized clinical trials)

• Design, analysis and interpretation of population-based studies (observational epidemiologic studies).

Program management and scientific involvement with the following studies either solely or in collaboration with Division staff:

            • The Folic Acid for Vascular Outcome Reduction (FAVORIT) Trial

            • The Dialysis Access Consortium (DAC)

            • The Program to Reduce Incontinence by Diet and Exercise (PRIDE)

            • The Boston Area Community Health (BACH) Survey

            • The Chronic Renal Insufficiency Cohort (CRIC) Study

            • The Urinary Incontinence treatment (UITN) Network

            • The Interstitial Cystitis Clinical Research Network (ICCRN)

            • The Chronic Prostatitis Collaborative Research Network (CPCRN)

            • The Chronic Kidney Disease (CKD) Epidemiology Project

            • The Minimally Invasive Surgical Therapy (MIST) Consortium

            • The Complementary and Alternative Medicine for Urological Symptoms (CAMUS)

            • The Oral versus IV iron trial

            • The African American Study of Kidney Disease and Hypertension (AASK) Cohort Study 
     • The Clinical Trial of Alpha-Blocker for Patients with Urinary Tract Stones (STONE Study)

1979 Ph.D., University of Michigan, Ann Arbor, Michigan

1979-1983: Faculty, Department of Epidemiology and Biometry, School of Public Health, University of Illinois, Chicago, Illinois

1983-1989: Division of Lung Diseases, National Heart, Lung, and Blood Institute